Leveraging Big Data and Artificial Intelligence for Smarter Trials in Myeloproliferative Neoplasms
Frontiers in Hematology（2024）
Key words
myeloproliferative neoplasms (MPNs),machine learning (ML),artificial intelligence (AI),clinical trials,prognostication,risk stratification
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined